Shuttle Pharmaceuticals, UCFS Strike Sponsored Research Agreement
Collaboration aims to enhance PSMA-B ligand, a novel theranostic molecule in development for the treatment of prostate cancer.
August 16, 2026
Collaboration aims to enhance PSMA-B ligand, a novel theranostic molecule in development for the treatment of prostate cancer.